General Information of Drug (ID: DM1O7PR)

Drug Name
Peptide-T
Synonyms Peptide T; Peptide-T, Carlbiotech; Peptide-T, Peptech
Indication
Disease Entry ICD 11 Status REF
Neurodegenerative disorder 8A20-8A23 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C35H55N9O16
Canonical SMILES
CC(C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CO)NC(=O)C(C)N)O
InChI
1S/C35H55N9O16/c1-13(36)28(52)40-22(12-45)31(55)41-25(15(3)47)33(57)43-26(16(4)48)34(58)42-24(14(2)46)32(56)39-21(11-23(37)51)29(53)38-20(10-18-6-8-19(50)9-7-18)30(54)44-27(17(5)49)35(59)60/h6-9,13-17,20-22,24-27,45-50H,10-12,36H2,1-5H3,(H2,37,51)(H,38,53)(H,39,56)(H,40,52)(H,41,55)(H,42,58)(H,43,57)(H,44,54)(H,59,60)/t13-,14+,15+,16+,17+,20-,21-,22-,24-,25-,26-,27-/m0/s1
InChIKey
IWHCAJPPWOMXNW-LYKMMFCUSA-N
Cross-matching ID
PubChem CID
73352
CAS Number
106362-32-7
TTD ID
D0W4VH

References

1 ClinicalTrials.gov (NCT00000392) Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.. U.S. National Institutes of Health.